Pennant Investors »

Allogene Therapeutics shares owned by Pennant Investors

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Pennant Investors from 13F filings

Historical chart of Pennant Investors investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Pennant Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Pennant Investors

Quarter filed Position value Share count Share price at filing
2024-03-31 $574k 128k 4.47

More positions owned by Pennant Investors

Amazon (AMZN)
TransDigm Group Incorporated (TDG)
Antero Res Call Option (AR)
Microsoft Corporation (MSFT)
Micron Technology (MU)
Echostar Corp Cl A (SATS)
Alphabet Cap Stk Cl A (GOOGL)
Apple Put Option (AAPL)
Colfax Corp (ENOV)
ODP Corp. (ODP)
Perimeter Solutions Sa Common Stock (PRM)
Fibrogen (FGEN)
Arcutis Biotherapeutics (ARQT)
Altimmune Com New (ALT)
Fate Therapeutics (FATE)

View all positions for Pennant Investors

Top funds holding Allogene Therapeutics

Tpg Gp A
BlackRock
BlackRock
Vanguard Group
State Street Corporation
Capital World Investors
Lynx1 Capital Management
PRIMECAP Management Company
Citadel Advisors
T. Rowe Price Associates
Woodline Partners
Jpmorgan Chase & Co
Geode Capital Management
Two Sigma Investments
Wildcat Capital Management

View all funds holding Allogene Therapeutics